Literature DB >> 17273924

Effects of combination therapy with direct hemoperfusion using polymyxin B-immobilized fiber and oral vancomycin on fulminant pseudomembranous colitis with septic shock.

Yoshihide Kimura1, Koichi Sato, Hiroshi Tokuda, Naka Nakamura, Yasuaki Dohi, Etsuro Orito, Masashi Mizokami.   

Abstract

We report 2 cases of fulminant pseudomembranous colitis with septic shock. The first case showed few symptoms, whereas the second case showed recurrence. Both cases rapidly developed shock and blood pressure was uncontrollable except with the use of pressor agents. Direct hemoperfusion using polymyxin B-immobilized fiber, which was previously demonstrated to have excellent therapeutic effects for the treatment of hypotension in septic shock by removing circulating lipopolysaccharide and oral vancomycin dramatically improved both cases' clinical status and decreased their APACHE II scores (from 18 to 8 and from 16 to 9 points, respectively). Therefore, we suggest that direct hemoperfusion using polymyxin B-immobilized fiber improved hypotension-correcting cytokine balance with adsorption of endogenous cannabinoids in serum. Although colectomy is often performed to treat fulminant pseudomembranous colitis with septic shock, direct hemoperfusion can be easily performed with little risk to the patient. These cases strongly indicated that our combination therapy provides an important treatment for fulminant pseudomembranous colitis with septic shock.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273924     DOI: 10.1007/s10620-006-9494-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  15 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

Review 2.  Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis.

Authors:  R J Farrell; J T LaMont
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

3.  Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.

Authors:  Ramsey M Dallal; Brian G Harbrecht; Arthur J Boujoukas; Carl A Sirio; Linda M Farkas; Kenneth K Lee; Richard L Simmons
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

4.  Neutralization of the hemodynamic effects of endotoxin by polymyxin B.

Authors:  J D Palmer; D Rifkind
Journal:  Surg Gynecol Obstet       Date:  1974-05

5.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

6.  Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial.

Authors:  R Fekety; L V McFarland; C M Surawicz; R N Greenberg; G W Elmer; M E Mulligan
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

7.  Mechanism of the hypotensive action of anandamide in anesthetized rats.

Authors:  K Varga; K D Lake; D Huangfu; P G Guyenet; G Kunos
Journal:  Hypertension       Date:  1996-10       Impact factor: 10.190

8.  Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.

Authors:  H Aoki; M Kodama; T Tani; K Hanasawa
Journal:  Am J Surg       Date:  1994-04       Impact factor: 2.565

9.  Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.

Authors:  G Hecht; C Pothoulakis; J T LaMont; J L Madara
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

Review 10.  The cannabinoid system and cytokine network.

Authors:  T W Klein; B Lane; C A Newton; H Friedman
Journal:  Proc Soc Exp Biol Med       Date:  2000-10
View more
  1 in total

1.  Successful treatments with polymyxin B hemoperfusion and recombinant human thrombomodulin for fulminant Clostridium difficile-associated colitis with septic shock and disseminated intravascular coagulation: a case report.

Authors:  Kazuhito Minami; Yoshihisa Sakaguchi; Daisuke Yoshida; Manabu Yamamoto; Masahiko Ikebe; Masaru Morita; Yasushi Toh
Journal:  Surg Case Rep       Date:  2016-07-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.